Tisdag 12 Maj | 18:13:03 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2027-03-03 N/A Bokslutskommuniké 2026
2026-08-20 07:30 Kvartalsrapport 2026-Q2
2026-04-07 - X-dag ordinarie utdelning GUBRA 0.00 DKK
2026-03-26 - Årsstämma
2026-02-27 - Bokslutskommuniké 2025
2025-08-21 - Kvartalsrapport 2025-Q2
2025-06-30 - X-dag bonusutdelning GUBRA 61.2
2025-06-27 - Extra Bolagsstämma 2025
2025-04-04 - X-dag ordinarie utdelning GUBRA 0.00 DKK
2025-04-03 - Årsstämma
2025-02-28 - Bokslutskommuniké 2024
2024-08-23 - Kvartalsrapport 2024-Q2
2024-04-04 - X-dag ordinarie utdelning GUBRA 0.00 DKK
2024-04-03 - Årsstämma
2024-02-28 - Bokslutskommuniké 2023
2023-11-01 - Extra Bolagsstämma 2023
2023-08-25 - Kvartalsrapport 2023-Q2

Beskrivning

LandDanmark
ListaMid Cap Copenhagen
SektorHälsovård
IndustriBioteknik
Gubra är ett läkemedelsbolag. Bolagets verksamhet är fokuserad på de tidiga stadierna av läkemedelsutveckling. De driver huvudsakligen forskning och utveckling inom området för metabola och fibrotiska sjukdomar. Bolagets produktportfölj innefattar ett flertal varumärken och läkemedel, och verksamheten bedrivs på global nivå, med störst närvaro inom Nordamerika och Norden. Huvudkontoret ligger i Hørsholm, Danmark.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2026-05-12 16:41:00

Gubra A/S ("Gubra" or the "Company") today announces its decision to launch a share matching program (the "Program") for employees of the Company and its subsidiaries, including members of the Company's Executive Management (each a "Participant"), with effect from 12 May 2026.
 
Under the Program, Participants may submit an offer to purchase shares in the Company during a defined offer window from 12 May 2026 until 31 May (the "Qualifying Shares"). Subject to the terms of the Program, the Qualifying Shares will subsequently be purchased on the market during one or more trading days, and the Participants will be granted the right to receive one matching share for each Qualifying Share, corresponding to a 1:1 match (the "Matching Shares").
 
The value of Qualifying Shares acquired by each Participant may not exceed 10% of the Participant’s annual base salary.
 
Matching Shares will vest after a period of 2 years and 4 months calculated from 1 June 2026, provided that the Participant has retained the Qualifying Shares throughout the vesting period and remains employed at the time of vesting, subject to customary good leaver and bad leaver provisions. Upon vesting, Matching Shares will be delivered to the Participant in shares or, at the Company's discretion, settled in cash.
 
The Company expects to satisfy its obligations under the Program through the acquisition and holding of treasury shares.
 
For members of the Executive Management, the Program is subject to the framework set out in the Company's Remuneration Policy, as approved at the annual general meeting of the Company on 26 March 2026 and available on the Company’s website.